Latest
-
Today’s landmark approval by the US Food and Drug Administration of Vertex Pharmaceuticals’ and CRISPR Therapeutics’ EXA-cell, the world’s first CRISPR-based treatment, marks a groundbreaking shift in how we tackle intractable diseases.
-
Overages penalize your customers for buying more. You could generate more revenue by instead tiering pricing for how your customers want to consume.
-
Smart energy grids. Voice-first companion apps. Programmable medicines. AI tools for kids. We asked over 40 partners across a16z to preview one big idea they believe will drive innovation in the coming year.
-
Most growth-stage CEOs know how to tell if they’re efficiently allocating capital in every part of their budget with one glaring exception: research and development (R&D).
-
We believe a strong America means a strong world. A safer world. A more civilized world, which is a term we should use more. And that technology is the backbone of maintaining this order and civilization and always will be.
-
Our view is that 1) the latest advancements in AI offer a massive enablement opportunity to support our clinicians and 2) this can’t happen without the help of forward-thinking policymakers laying the infrastructure for AI-enabled care.
-
It’s the jolliest chapter of the 365! Deck the halls and share the gifting spirit because it’s time to play Santa with style and substance. This year, Talent x Opportunity founders are helping spread good cheer w...
-
Each new modality needs to find its platform-disease fit—the diseases it is uniquely suited for. But finding fit has increasingly turned into a fight; many have crowded into the same indications. With an expanding arsenal to treat disease, how will patients, clinicians, and the market determine what tool to use?
-
While the Google --> WebMD --> Friend protocol may be a common way to enter into the healthcare system, it is certainly not an optimal one. Most of us are not well-equipped to self-diagnose from a list of possible conditions, and our friends who work in healthcare often don’t have the exact expertise we need.
-
In April, the first viral AI cover dropped. More innovation in music and generative AI is coming, and here's what it might look like.
Recent Investment News
-
Investing in Air Space Intelligence
David Ulevitch -
Investing in Gate Bioscience
Vineeta Agarwala -
Investing in Prepared
David Ulevitch -
Investing in Blackbird
Arianna Simpson -
Investing in Proof of Play
Chris Dixon -
Investing in TipTop
Marc Andreessen -
Investing in Series AI
Joshua Lu -
Investing in Moment
David Haber -
Load More Recent Investment News